Percutaneous cryoablation for stage T1b tumours

A recent study published in Cardiovascular and Interventional Radiology this month looked at the use of percutaneous cryoablation for stage T1b (4.1-7.0 cm) renal cell carcinoma (RCC). This non-invasive technique, which involves ‘freezing’ the tumour using fine needles inserted through the skin (percutaneous), has not yet been widely adopted. The current study investigated the safety, […]

read more

CAR can be used to indicate survival in kidney cancer patients

A recent study with Japanese patients, published in Urologic Oncology last month, provides evidence to suggest that the ratio of two proteins in the blood (C-reactive protein and albumin ratio, CAR) before surgery is an independent prognostic indicator of overall survival, cancer-specific survival and recurrence-free survival for patients with renal cell carcinoma (RCC). Because CAR […]

read more

Overall survival data for kidney cancer patients treated with high dose interleukin-2

A retrospective study recently reported in Journal for Immunotherapy of Cancer looked at the survival of renal cell carcinoma (RCC) patients who were assessed using the International Metastatic RCC Database Consortium (IMDC) for RCC risk and treated with high dose interleukin-2 (IL-2). These patients were entered on the PROCLAIMSM data base. The patients were followed […]

read more

Exercise significantly cuts the risk of death from cancer

New research from an American group based at Roswell Park Comprehensive Cancer Center, New York shows that if cancer patients exercise regularly both before and after their diagnosis, they are significantly more likely to survive cancer than those who are sedentary. This adds to the growing evidence that physical activity is important for the prevention […]

read more

Historical outcomes in metastatic renal cell carcinoma

The following OncLive video interview with two leading renal cell carcinoma (RCC) experts, Dr Brian Rini, Cleveland Clinic Lerner College of Medicine, and Dr David McDermott, Harvard Cancer Center, summarises how the treatment and prognosis of metastatic RCC has changed over recent years, and looks forward to the advent of combination therapies in the future. Watch […]

read more

Renal biopsy has a low risk of cancer spread to the fat surrounding the kidney

A recent study has shown that the risk of spread of cancer cells to the fat surrounding the kidney (perinephric fat) during a biopsy for renal cell carcinoma (RCC) is very small, and occurred in only 1.2% of cases. In these cases, a renal mass biopsy resulted in the stage of the cancer changing from […]

read more

Stereotactic body radiotherapy may improve control of localised kidney cancer

A recent study published in The Journal of Urology this month suggests that stereotactic body radiotherapy (SBRT) may be a safe and effective therapeutic option that could control the growth of localised, small numbers of metastases (oligometastatic) in people with advanced renal cell carcinoma (RCC). Fifty-eight RCC patients, who had undergone surgery and had a maximum […]

read more

Potential biomarkers may predict response to TKIs in metastatic kidney cancer

A recent study published in Clinical Cancer Research and conducted in France has identified potential biological markers that are related to the formation of new blood vessels (angiogenesis) and regulated by the levels of oxygen reaching the tissues (hypoxia). These biomarkers have been found to be strong predictors of response, progression-free survival (PFS), and overall survival […]

read more

Active surveillance of small renal masses

This study, involving 450 people, provides evidence in favour of active surveillance for small renal masses. The researchers looked at the outcomes of patients with kidney masses who chose active surveillance rather than immediate surgery. The study found that patients who need surgery are often identified early and those who remain on active surveillance become […]

read more

BMI may be related to survival outcomes for non-metastatic kidney cancer

A new study published in Journal of Surgical Oncology last month suggests that high body mass index (BMI) may be related to improved recurrence-free and cancer-specific survival among older patients with non-metastatic clear cell renal cell carcinoma (RCC). It is known that obesity is a risk factor for the development of RCC, but evidence for how obesity […]

read more
Showing 21 to 30 of 67 results
  TOP